General information about company
Scrip code	523489
NSE Symbol	NA
MSEI Symbol	NA
ISIN*	INE889F01017
Name of company	CHENNAI MEENAKSHI MULTISPECIALITY HOSPITAL LTD
Type of company
Class of security	Equity
Date of start of financial year	01-04-2020
Date of end of financial year	31-03-2021
Date of board meeting when results were approved	28-06-2021
Date on which prior intimation of the meeting for considering financial results was informed to the exchange	12-06-2021
Description of presentation currency	INR
Level of rounding used in financial results	Lakhs
Reporting Quarter	Yearly
Nature of report standalone or consolidated	Standalone
Whether results are audited or unaudited	Audited
Segment Reporting	Single segment
Description of single segment	HEALTH CARE SERVICES
Start date and time of board meeting	28-06-2021 16:00
End date and time of board meeting	28-06-2021 17:30
Whether cash flow statement is applicable on company	Yes
Type of cash flow statement	Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification	Declaration of unmodified opinion

Financial Results – Ind-AS
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-01-2021	01-04-2020
B	Date of end of reporting period	31-03-2021	31-03-2021
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Standalone	Standalone
Part I	Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1	Income
	Revenue from operations	583.81	1940.96
	Other income	18.66	59.13
	Total income	602.47	2000.09
2	Expenses
(a)	Cost of materials consumed	0	0
(b)	Purchases of stock-in-trade	140.97	456.43
(c)	Changes in inventories of finished goods, work-in-progress and stock-in-trade	5.1	10.66
(d)	Employee benefit expense	190.16	692.31
(e)	Finance costs	24.14	113.9
(f)	Depreciation, depletion and amortisation expense	32.96	126.72
(f)	Other Expenses
1	Other Expenses	210.07	725.05
10
	Total other expenses	210.07	725.05
	Total expenses	603.4	2125.07

Financial Results – Ind-AS
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-01-2021	01-04-2020
B	Date of end of reporting period	31-03-2021	31-03-2021
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Standalone	Standalone
Part I	Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
3	Total profit before exceptional items and tax	-0.93	-124.98
4	Exceptional items	4.01	4.01
5	Total profit before tax	3.08	-120.97
7	Tax expense
8	Current tax	0	0
9	Deferred tax	0	0
10	Total tax expenses	0	0
11	Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement	0	0
14	Net Profit Loss for the period from continuing operations	3.08	-120.97
15	Profit (loss) from discontinued operations before tax	0	0
16	Tax expense of discontinued operations	0	0
17	Net profit (loss) from discontinued operation after tax	0	0
19	Share of profit (loss) of associates and joint ventures accounted for using equity method	0	0
21	Total profit (loss) for period	3.08	-120.97
22	Other comprehensive income net of taxes	0	0

Financial Results – Ind-AS
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-01-2021	01-04-2020
B	Date of end of reporting period	31-03-2021	31-03-2021
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Standalone	Standalone
Part I	Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
23	Total Comprehensive Income for the period	3.08	-120.97
24	Total profit or loss, attributable to
	Profit or loss, attributable to owners of parent
	Total profit or loss, attributable to non-controlling interests
25	Total Comprehensive income for the period attributable to
	Comprehensive income for the period attributable to owners of parent	0	0
	Total comprehensive income for the period attributable to owners of parent non-controlling interests	0	0
26	Details of equity share capital
	Paid-up equity share capital	746.89	746.89
	Face value of equity share capital	10	10
27	Details of debt securities
28	Reserves excluding revaluation reserve		0
29	Earnings per share
i	Earnings per equity share for continuing operations
	Basic earnings (loss) per share from continuing operations	-0.01	-1.67
	Diluted earnings (loss) per share from continuing operations	-0.01	-1.67
ii	Earnings per equity share for discontinued operations
	Basic earnings (loss) per share from discontinued operations	0	0
	Diluted earnings (loss) per share from discontinued operations	0	0
ii	Earnings per equity share
	Basic earnings (loss) per share from continuing and discontinued operations	-0.01	-1.67
	Diluted earnings (loss) per share from continuing and discontinued operations	-0.01	-1.67
30	Debt equity ratio	0	0
31	Debt service coverage ratio	0	0
32	Interest service coverage ratio	0	0
33	Disclosure of notes on financial results

Statement of Asset and Liabilities
Particulars		Current year ended (dd-mm-yyyy)
Date of start of reporting period		01-04-2020
Date of end of reporting period		31-03-2021
Whether results are audited or unaudited		Audited
Nature of report standalone or consolidated		Standalone
	Assets
1	Non-current assets
	Property, plant and equipment	1286.77
	Capital work-in-progress	11.98
	Investment property	0
	Goodwill	0
	Other intangible assets	0
	Intangible assets under development	0
	Biological assets other than bearer plants	0
	Investments accounted for using equity method	0
	Non-current financial assets
	Non-current investments	0
	Trade receivables, non-current	0
	Loans, non-current	0
	Other non-current financial assets	25.17
	Total non-current financial assets	25.17
	Deferred tax assets (net)	0
	Other non-current assets	0
	Total non-current assets	1323.92
2	Current assets
	Inventories	57.74
	Current financial asset
	Current investments	0
	Trade receivables, current	78.85
	Cash and cash equivalents	309.75
	Bank balance other than cash and cash equivalents	0
	Loans, current	0
	Other current financial assets	133.67
	Total current financial assets	522.27
	Current tax assets (net)
	Other current assets	16.2
	Total current assets	596.21

Statement of Asset and Liabilities
Particulars		Current year ended (dd-mm-yyyy)
Date of start of reporting period		01-04-2020
Date of end of reporting period		31-03-2021
Whether results are audited or unaudited		Audited
Nature of report standalone or consolidated		Standalone
3	Non-current assets classified as held for sale	0
4	Regulatory deferral account debit balances and related deferred tax Assets	0
	Total assets	1920.13
	Equity and liabilities
	Equity
	Equity attributable to owners of parent
	Equity share capital	746.89
	Other equity	-1223.92
	Total equity attributable to owners of parent	-477.03
	Non controlling interest
	Total equity	-477.03
	Liabilities
	Non-current liabilities
	Non-current financial liabilities
	Borrowings, non-current	1147.64
	Trade payables, non-current	0
	Other non-current financial liabilities	0
	Total non-current financial liabilities	1147.64
	Provisions, non-current	67.7
	Deferred tax liabilities (net)	0
	Deferred government grants, Non-current	0
	Other non-current liabilities	0
	Total non-current liabilities	1215.34
	Current liabilities
	Current financial liabilities
	Borrowings, current	0
	Trade payables, current	150.4
	Other current financial liabilities	1016.51
	Total current financial liabilities	1166.91
	Other current liabilities	0
	Provisions, current	14.91
	Current tax liabilities (Net)	0
	Deferred government grants, Current	0
	Total current liabilities	1181.82
3	Liabilities directly associated with assets in disposal group classified as held for sale	0
4	Regulatory deferral account credit balances and related deferred tax liability	0
	Total liabilities	2397.16
	Total equity and liabilites	1920.13
	Disclosure of notes on assets and liabilities	Textual Information(1)

Text Block

Textual Information(1)

Board of Directors approved the Audited Fin Results for the YE 31.03.2021. The appd Results along with audit reportand declaration on the report of auditors with Unmodified opinion are enclosed as Annexure; The Board of Directors has not recommended any Dividend for the year 2020-21;The fin results have been prepared in accordance with Ind AS as notified by the MCA pursuant to Sec133 of the Companies Act,2013 read with Rule3 of the Co(IndAS)Rules,2015 and Com(Indian Accounting Standards) Amendment Rules,2016; The Company is mainly in the business of “Hospitals”. Hence there is no separate reportable segment as per AS17 issued by the ICAI; The figures for the QE31.03.2021 are the balancing figures between audited figures in respect of the full financial year and the published year to date figures upto the third quarter of the relevant financial year; The Board decided to conduct the next AGM on Wednesday, 15.09.2021; The Book-Closure for the purpose of AGM from 09.09.2021(Thursday) to 15.09.2021(Wednesday). The Record Date for purpose of AGMeeting will be 08.09.2021(Wednesday);The Board recommended to place the required resolution to the ensuing AGM for appointment of Mrs.R. Gomathi, (DIN:02900460) MD of the Co for a period of 3 years from 11.11.2020;The Board appd the retirement and re-appointment of Mr.A.N.Radhakrishnan (DIN:01508867) as Director subject to approval in the ensuing AGM;The Board recommended to place the required resolution in the ensuing AGM for appointment of Mrs.K.Meyyanathan,(DIN.07845698)as Ind Director;The Boardrecommended to place the required resolution in the ensuing AGM for appointment of Mr. N. Rajkumar (DIN NO.00617000) as Ind Director of the Co.;The Board appd for incurring Capital Expenditure not exceeding Rs.65 Lakhs and Revenue expenditure not exceeding Rs.50 Lakhs during the financial year 2021-22;The meeting commenced at 16.00 Hours and concluded at 17.30 Hours.

Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars		3 months/ 6 month ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period		01-01-2021	01-04-2020
Date of end of reporting period		31-03-2021	31-03-2021
Whether accounts are audited or unaudited		Audited	Audited
Nature of report standalone or consolidated		Standalone	Standalone
1	Segment Revenue (Income)
	(net sale/income from each segment should be disclosed)
	Total Segment Revenue
	Less: Inter segment revenue
	Revenue from operations
2	Segment Result
	Profit (+) / Loss (-) before tax and interest from each segment
	Total Profit before tax
	i. Finance cost
	ii. Other Unallocable Expenditure net off Unallocable income
	Profit before tax
3	(Segment Asset - Segment Liabilities)
	Segment Asset
	Total Segment Asset
	Un-allocable Assets
	Net Segment Asset
4	Segment Liabilities
	Segment Liabilities
	Total Segment Liabilities
	Un-allocable Liabilities
	Net Segment Liabilities
	Disclosure of notes on segments

Cash flow statement, indirect
Particulars		Year ended (dd-mm-yyyy)
A	Date of start of reporting period	01-04-2020
B	Date of end of reporting period	31-03-2021
C	Whether results are audited or unaudited	Audited
D	Nature of report standalone or consolidated	Standalone
Part I	Blue color marked fields are non-mandatory.
	Statement of cash flows
	Cash flows from used in operating activities
	Profit before tax	-120.97
	Adjustments for reconcile profit (loss)
	Adjustments for finance costs	113.89
	Adjustments for decrease (increase) in inventories	10.65
	Adjustments for decrease (increase) in trade receivables, current	122.55
	Adjustments for decrease (increase) in trade receivables, non-current	0
	Adjustments for decrease (increase) in other current assets	0
	Adjustments for decrease (increase) in other non-current assets	0
	Adjustments for other financial assets, non-current	0
	Adjustments for other financial assets, current	11.18
	Adjustments for other bank balances	0
	Adjustments for increase (decrease) in trade payables, current	96.13
	Adjustments for increase (decrease) in trade payables, non-current	0
	Adjustments for increase (decrease) in other current liabilities	0
	Adjustments for increase (decrease) in other non-current liabilities	0
	Adjustments for depreciation and amortisation expense	126.72
	Adjustments for impairment loss reversal of impairment loss recognised in profit or loss	0.08
	Adjustments for provisions, current	0
	Adjustments for provisions, non-current	0
	Adjustments for other financial liabilities, current	0
	Adjustments for other financial liabilities, non-current	0
	Adjustments for unrealised foreign exchange losses gains	0
	Adjustments for dividend income	0
	Adjustments for interest income	13.98
	Adjustments for share-based payments	0
	Adjustments for fair value losses (gains)	0
	Adjustments for undistributed profits of associates	0
	Other adjustments for which cash effects are investing or financing cash flow	0
	Other adjustments to reconcile profit (loss)	0
	Other adjustments for non-cash items	0
	Share of profit and loss from partnership firm or association of persons or limited liability partnerships	0
	Total adjustments for reconcile profit (loss)	467.22
	Net cash flows from (used in) operations	346.25
	Dividends received	0
	Interest paid	113.89
	Interest received	13.99
	Income taxes paid (refund)	0
	Other inflows (outflows) of cash	0
	Net cash flows from (used in) operating activities	246.35
	Cash flows from used in investing activities
	Cash flows from losing control of subsidiaries or other businesses	0
	Cash flows used in obtaining control of subsidiaries or other businesses	0
	Other cash receipts from sales of equity or debt instruments of other entities	0
	Other cash payments to acquire equity or debt instruments of other entities	0
	Other cash receipts from sales of interests in joint ventures	0
	Other cash payments to acquire interests in joint ventures	0
	Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships	0
	Cash payment for investment in partnership firm or association of persons or limited liability partnerships	0
	Proceeds from sales of property, plant and equipment	0.04
	Purchase of property, plant and equipment	28.06
	Proceeds from sales of investment property	0
	Purchase of investment property	0
	Proceeds from sales of intangible assets	0
	Purchase of intangible assets	0
	Proceeds from sales of intangible assets under development	0
	Purchase of intangible assets under development	0
	Proceeds from sales of goodwill	0
	Purchase of goodwill	0
	Proceeds from biological assets other than bearer plants	0
	Purchase of biological assets other than bearer plants	0
	Proceeds from government grants	0
	Proceeds from sales of other long-term assets	0
	Purchase of other long-term assets	0
	Cash advances and loans made to other parties	0
	Cash receipts from repayment of advances and loans made to other parties	0
	Cash payments for future contracts, forward contracts, option contracts and swap contracts	0
	Cash receipts from future contracts, forward contracts, option contracts and swap contracts	0
	Dividends received	0
	Interest received	0
	Income taxes paid (refund)	0
	Other inflows (outflows) of cash	0
	Net cash flows from (used in) investing activities	-28.02
	Cash flows from used in financing activities
	Proceeds from changes in ownership interests in subsidiaries	0
	Payments from changes in ownership interests in subsidiaries	0
	Proceeds from issuing shares	0
	Proceeds from issuing other equity instruments	0
	Payments to acquire or redeem entity's shares	0
	Payments of other equity instruments	0
	Proceeds from exercise of stock options	0
	Proceeds from issuing debentures notes bonds etc	0
	Proceeds from borrowings	0
	Repayments of borrowings	0
	Payments of finance lease liabilities	0
	Payments of lease liabilities	0
	Dividends paid	0
	Interest paid	0
	Income taxes paid (refund)	0
	Other inflows (outflows) of cash	0
	Net cash flows from (used in) financing activities	0
	Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes	218.33
	Effect of exchange rate changes on cash and cash equivalents
	Effect of exchange rate changes on cash and cash equivalents	0
	Net increase (decrease) in cash and cash equivalents	218.33
	Cash and cash equivalents cash flow statement at beginning of period	91.41
	Cash and cash equivalents cash flow statement at end of period	309.74